Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

3 terminated out of 66 trials

Success Rate

88.5%

+2.0% vs benchmark

Late-Stage Pipeline

18%

12 trials in Phase 3/4

Results Transparency

17%

4 of 23 completed with results

Key Signals

4 with results88% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (22)
P 2 (1)
P 3 (5)
P 4 (7)

Trial Status

Completed23
Unknown19
Recruiting12
Not Yet Recruiting4
Terminated3
Withdrawn2

Trial Success Rate

88.5%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (66)

Showing 20 of 20 trials
NCT05779787Recruiting

COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)

NCT06000943Recruiting

Ischemic And Bleeding Risk Assessment After TAVR

NCT06420830Recruiting

Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.

NCT04139616Recruiting

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR

NCT06983938Not ApplicableCompletedPrimary

This Study Will Evaluate the Safety and Potential Complications of Dual ProGlide vs Single ProGlide and Angioseal for Common Femoral Arteriotomy Closure Following Transcatheter Aortic Valve Replacement

NCT07411768Not ApplicableNot Yet RecruitingPrimary

Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement

NCT07453849Not ApplicableNot Yet Recruiting

TAVR for Aortic Regurgitation Under TEE Guidance

NCT07329660Not ApplicableNot Yet RecruitingPrimary

Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients

NCT07370467Not Yet Recruiting

Transcatheter Mitral and Tricuspid Interventions: a Cardiac Magnetic Resonance Study

NCT06871774Not ApplicableRecruitingPrimary

Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR

NCT05881291Phase 4Completed

Efficacy and Safety of Ciprofol for General Anaesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement

NCT04107038Not ApplicableCompletedPrimary

Monitored Anesthesia Care vs. General Anesthesia for Transcatheter Aortic Valve Replacement

NCT04870424Phase 3CompletedPrimary

Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

NCT05217888Completed

The Sentinel Registry

NCT05791344TerminatedPrimary

Intra-procedural ECG Changes During TAVR

NCT05465655Not ApplicableTerminatedPrimary

Cara CDRM (Conduction Disturbance Risk Monitor) 2.0

NCT05657912CompletedPrimary

Cara CDRS (Conduction Disturbance Risk Score) 1.0

NCT06962371Not ApplicableRecruiting

Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)

NCT05758701Phase 4RecruitingPrimary

CT TAVR Abdomen Study

NCT06518317Phase 3RecruitingPrimary

Short Versus Long Antiplatelet Therapy After TAVI

Scroll to load more

Research Network

Activity Timeline